Inogen

Inogen Financial Leverage

The Financial Leverage (Equity Multiplier) of Inogen (INGN) as of Oct 6, 2026 is 1.55. In the previous year, Financial Leverage (Equity Multiplier) was 1.70 — a change of -8.81% (lower).

Financial Leverage

1.55

YoY

-8.81%

Last updated:

Financial Leverage (Equity Multiplier) of Inogen is 2026 1.55 . Financial Leverage (Equity Multiplier) of Inogen was 2025 1.70 . It decreases by -8.81% lower compared to the previous year.

The Inogen Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.21 USD
Jan 1, 2019
1.30 USD
Jan 1, 2020
1.32 USD
Jan 1, 2021
1.32 USD
Jan 1, 2022
1.36 USD
Jan 1, 2023
1.59 USD
Jan 1, 2024
1.70 USD
Jan 1, 2025
1.55 USD
The Inogen Financial Leverage history
YEARFinancial LeverageYoY
1.55-8.81%
1.70+6.97%
1.59+16.94%
1.36+3.00%
1.32+0.09%
1.32+1.77%
1.30+7.20%
1.21-0.05%
1.21+3.06%
1.18-2.34%
1.20+1.52%
1.19—
Access this data via the Eulerpool API

Inogen Stock analysis

What does Inogen do? Inogen Inc. is an American company that specializes in the development and manufacturing of oxygen concentrators. The company was founded in 2001 and is headquartered in Goleta, California. Inogen has become a market leader in portable oxygen concentrators in the American market. The company offers high-quality products and services to improve the lives of patients with chronic lung problems. Inogen focuses on improving the quality of life by developing and manufacturing high-quality, durable, and reliable portable oxygen concentrators that integrate all necessary features for optimal mobility and freedom. It offers various products and services for patients, doctors, insurance companies, and community centers. Some of its products include the Inogen One G5, Inogen One G4, Inogen TAV, Inogen Carry Bag, and Inogen Battery. In summary, Inogen Inc. is a specialized company in the development and manufacturing of oxygen concentrators, with a focus on improving the lives of patients with chronic lung problems through high-quality portable solutions. Inogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inogen stock

Financial Leverage (Equity Multiplier) of Inogen is 1.55 in 2026.

Financial Leverage (Equity Multiplier) of Inogen changed from 1.70 to 1.55, representing a -8.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Inogen since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Inogen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Inogen

All Key Metrics — Inogen